Unknown

Dataset Information

0

Genotyping Multidrug-Resistant Mycobacterium tuberculosis from Primary Sputum and Decontaminated Sediment with an Integrated Microfluidic Amplification Microarray Test.


ABSTRACT: There is a growing awareness that molecular diagnostics for detect-to-treat applications will soon need a highly multiplexed mutation detection and identification capability. In this study, we converted an open-amplicon microarray hybridization test for multidrug-resistant (MDR) Mycobacterium tuberculosis into an entirely closed-amplicon consumable (an amplification microarray) and evaluated its performance with matched sputum and sediment extracts. Reproducible genotyping (the limit of detection) was achieved with ?25 M. tuberculosis genomes (100 fg of M. tuberculosis DNA) per reaction; the estimated shelf life of the test was at least 18 months when it was stored at 4°C. The test detected M. tuberculosis in 99.1% of sputum extracts and 100% of sediment extracts and showed 100% concordance with the results of real-time PCR. The levels of concordance between M. tuberculosis and resistance-associated gene detection were 99.1% and 98.4% for sputum and sediment extracts, respectively. Genotyping results were 100% concordant between sputum and sediment extracts. Relative to the results of culture-based drug susceptibility testing, the test was 97.1% specific and 75.0% sensitive for the detection of rifampin resistance in both sputum and sediment extracts. The specificity for the detection of isoniazid (INH) resistance was 98.4% and 96.8% for sputum and sediment extracts, respectively, and the sensitivity for the detection of INH resistance was 63.6%. The amplification microarray reported the correct genotype for all discordant phenotype/genotype results. On the basis of these data, primary sputum may be considered a preferred specimen for the test. The amplification microarray design, shelf life, and analytical performance metrics are well aligned with consensus product profiles for next-generation drug-resistant M. tuberculosis diagnostics and represent a significant ease-of-use advantage over other hybridization-based tests for diagnosing MDR tuberculosis.

SUBMITTER: Linger Y 

PROVIDER: S-EPMC5824040 | biostudies-literature | 2018 Mar

REPOSITORIES: biostudies-literature

altmetric image

Publications

Genotyping Multidrug-Resistant Mycobacterium tuberculosis from Primary Sputum and Decontaminated Sediment with an Integrated Microfluidic Amplification Microarray Test.

Linger Yvonne Y   Knickerbocker Christopher C   Sipes David D   Golova Julia J   Franke Molly M   Calderon Roger R   Lecca Leonid L   Thakore Nitu N   Holmberg Rebecca R   Qu Peter P   Kukhtin Alexander A   Murray Megan B MB   Cooney Christopher G CG   Chandler Darrell P DP  

Journal of clinical microbiology 20180222 3


There is a growing awareness that molecular diagnostics for detect-to-treat applications will soon need a highly multiplexed mutation detection and identification capability. In this study, we converted an open-amplicon microarray hybridization test for multidrug-resistant (MDR) <i>Mycobacterium tuberculosis</i> into an entirely closed-amplicon consumable (an amplification microarray) and evaluated its performance with matched sputum and sediment extracts. Reproducible genotyping (the limit of d  ...[more]

Similar Datasets

| S-EPMC6461559 | biostudies-literature
| S-EPMC2650920 | biostudies-literature
| S-EPMC1783141 | biostudies-literature
| S-EPMC2276497 | biostudies-literature
| S-EPMC4641146 | biostudies-literature
| S-EPMC2871542 | biostudies-literature
| S-EPMC6167964 | biostudies-literature
| S-EPMC6233677 | biostudies-literature
| S-EPMC4290937 | biostudies-literature
| S-EPMC5567934 | biostudies-literature